She Leads Biotech

She Leads Biotech

By Sharron CoxScienceLife Sciences
Download on the App Store

She Leads Biotech episodes

  • From Engineer to CEO

    From Engineer to CEO: Building the Future of Cell Therapy | Lucy Foley | What does it take to go from biochemical engineer to CEO of a company helping shape the future of cell and gene therapy?In this episode of She Leads Biotech, I'm joined by Lucy Foley, CEO of Exmoor Pharma, for a fascinating conversation about career progression, leadership, manufacturing innovation and the future of advanced therapies.Lucy's career has taken her from academia and biochemical engineering to designing manufacturing facilities, leading operations and eventually stepping into the CEO role at Exmoor Pharma.But her journey hasn't followed a conventional path.From a chance connection at an industry conference that changed her career trajectory to taking over the leadership of a founder-led business, Lucy shares the experiences, decisions and relationships that helped shape her success.In this episode, we explore:The future of cell and gene therapy: Why manufacturing remains one of the industry's biggest challenges and how automation could transform the production of advanced therapies.The power of networking: How putting herself in uncomfortable situations early in her career opened doors and created relationships that continue to influence her work today.Building a leadership team: Why a CEO is only as strong as the people around them, and how Lucy has strengthened Exmoor Pharma's executive team to support its next stage of growth.From CTO to CEO: The realities of stepping into a founder's shoes, building trust and empowering others to make decisions.Collaboration across the industry: Why sharing knowledge, experiences and even mistakes is essential to advancing cell and gene therapies.Scaling a biotech business: The challenges of expanding manufacturing capabilities while maintaining a strong company culture.Women in leadership:Lucy's perspective on confidence, the glass ceiling and why women should recognise the expertise they already bring to the table.One of the most interesting parts of our conversation is Lucy's belief that successful leadership isn't about having all the answers. It's about surrounding yourself with people who bring different perspectives, share responsibility and help move the business forward.We also discuss her vision for the future of cell therapy manufacturing, including a world where automation and robotics could make these complex treatments more scalable.An inspiring conversation about building a career, leading through change and helping make advanced therapies a reality for more patients.🎧 Subscribe to She Leads Biotech for more conversations with women shaping the future of biotechnology, life sciences and healthcare.Join our growing community!Subscribe to the *She Leads Biotech* newsletter for more leadership insights, inspiring stories and lessons from women across the life sciences industry.👉 https://sheleadsbiotech.substack.com/#SheLeadsBiotech #LucyFoley #CellTherapy #GeneTherapy #AdvancedTherapies #BiotechLeadership #WomenInBiotech #Biomanufacturing

    37 min
  • From Engineer to CEO


    What does it take to build a career in biotechnology when the opportunities don't always follow the path you originally imagined?

    This week on She Leads Biotech, I'm joined by Lucy Foley, CEO of Exmoor Pharma, whose journey from biochemical engineering to leading a cell and gene therapy company is full of unexpected opportunities, valuable connections and important leadership lessons.

    From academia and manufacturing to becoming CTO and eventually CEO, Lucy shares how her career evolved and why stepping outside her comfort zone made such a difference.

    We discuss the challenges of scaling cell and gene therapy manufacturing, the importance of collaboration across the industry and why automation could play a major role in making advanced therapies more accessible.

    Lucy also opens up about taking over from a founder, building a strong executive team, empowering others to make decisions and maintaining company culture through growth.

    And we explore women in leadership, confidence and why sometimes the biggest career opportunities begin with simply having the courage to start a conversation.

    A fascinating discussion about leadership, career progression and the future of cell therapy.

    🎧 Listen now to From Engineer to CEO: Building the Future of Cell Therapy.

    💌 Enjoyed this conversation? Join our growing She Leads Biotech community!

    Subscribe to our newsletter for more insights and stories from women shaping the future of life sciences.

    👉 https://sheleadsbiotech.substack.com/

    #SheLeadsBiotech #WomenInBiotech #CellTherapy #AdvancedTherapies #WomenInLeadership

    37 min
  • Brewing the Future of Medicine

    What if the future of medicine could be brewed rather than manufactured through traditional processes?

    In this episode of She Leads Biotech, I'm joined by Christina Smolke, Co-Founder & CEO, and Dr. Kristy Hawkins, Co-Founder & CSO of Antheia, to explore how they're using synthetic biology to transform pharmaceutical manufacturing.

    From their beginnings as professor and graduate student at Caltech to co-founding a biotechnology company, Christina and Kristy share the story behind their remarkable partnership.

    We discuss how Antheia uses engineered biology to produce essential medicines, why global pharmaceutical supply chains urgently need greater resilience, and what it takes to turn ambitious scientific research into commercial reality.

    We also explore the challenges of fundraising, leading scientific teams, learning to delegate and persevering when others believe something simply cannot be done.

    And perhaps most excitingly, we look at how this technology could create entirely new opportunities for drug discovery.

    A fascinating conversation about innovation, persistence, leadership and the future of medicine.

    🎧 Listen now to Brewing the Future of Medicine on She Leads Biotech.

    #SheLeadsBiotech #WomenInBiotech #SyntheticBiology #Biomanufacturing #FutureOfMedicine

    37 min
  • The Power of Asking Why

    What does a year in the CEO's chair teach you about everything you thought you knew?

    In this Then & Now episode of She Leads Biotech, I'm delighted to welcome back Denise Dajles, CEO of Cytrellis Biosystems, to discover what's changed since our first conversation.

    When we last spoke, Denise was navigating a major product relaunch, restructuring the business and finding her feet as a first-time CEO.

    A year later, she shares the realities of leading a growing MedTech company, from significant commercial growth and expanding her team to the unexpected challenges that have forced her to rethink her original plans.

    We explore why asking “why” has become central to her leadership approach, what she's learned about hiring people with the right attitude, and why building a team that can operate without her constant involvement is an important measure of success.

    Denise also discusses the difference between selling innovative technology and achieving lasting adoption, why authentic clinical evidence matters more than polished AI-generated images, and the responsibility that comes with leading a business whose employees and families depend on its success.

    What I particularly enjoyed was Denise's honesty about getting things wrong, adapting along the way and learning to trust the people around her.

    Because leadership isn't about always being right. It's about having the humility to question yourself and the determination to keep moving forward.

    🎧 Join me for another inspiring conversation on She Leads Biotech.

    #SheLeadsBiotech #DeniseDajles #MedTech #WomenInBiotech #Leadership #LifeSciences

    37 min
  • Learning What to Unlearn

    Can the experience that made you successful actually hold you back in your next role?

    In this episode of She Leads Biotech, I'm joined by Cathy Collis, Chief Commercial Officer at Renexxion Pharmaceuticals, to explore what happens when a career takes you from the structure and resources of big pharma into the unpredictable world of smaller biotech companies.

    Cathy shares her journey from public policy into pharmaceutical leadership, the lessons she's learned along the way and why adapting to a new environment sometimes means letting go of familiar ways of working.

    We discuss the importance of self-reliance, making decisions with limited resources, building the right commercial capabilities at the right time and recognising that the people who build a business aren't always the same people needed to scale it.

    We also explore patient advocacy, the importance of challenging assumptions and why commercial thinking should begin long before a treatment reaches the market.

    It's a conversation about career choices, leadership, adaptability and finding the confidence to do things differently.

    Because sometimes the most valuable thing we can learn is what we need to unlearn.

    🎧 Join me for another insightful conversation on She Leads Biotech.

    #SheLeadsBiotech #CathyCollis #WomenInBiotech #BiotechLeadership #LifeSciences

    35 min
  • From AI Platform to the Clinic: Making the Decisions That Change a Biotech

    What happens when a biotech company realises that its next stage of growth requires a completely different approach?

    In this episode of She Leads Biotech, I'm joined by Beverley Carr, Chief Business and Operating Officer at CHARM Therapeutics, to explore the realities of transforming promising science into a clinical-stage business.

    Beverley shares the decisions behind CHARM's shift from a broad AI drug discovery platform to a focused oncology programme, the challenges of restructuring a business for its next stage, and why having the right people in place matters just as much as having great science.

    We also discuss the real value of AI in drug discovery, the importance of making difficult decisions early, and Beverley's own journey from chemistry to biotech leadership.

    It's a conversation about adaptability, courage and recognising when the path forward requires doing things differently.

    Because sometimes the most important leadership decision isn't what to pursue next, but what you're prepared to leave behind.

    🎧 Listen now on She Leads Biotech.

    #SheLeadsBiotech #BiotechLeadership #WomenInBiotech #DrugDiscovery #LifeSciences

    31 min
  • Restoring Balance | Why Women Must Stop Outsourcing Their Health

    How much do we really understand about our own health, and how often have we been told that symptoms are simply "normal"?


    In this episode, I'm joined by Paula Soteropoulos, biotech executive and investor, and her daughter Dr. Alexia Soteropoulos, an integrative and functional medicine physician, to discuss their book Restoring Balance and why women need to take a more active role in understanding their bodies.


    We explore the gaps in women's health research, menopause, hormone health, whole-person care and the importance of questioning symptoms that are too often dismissed or normalised.

    Paula brings her perspective from biotech leadership and investment, while Alexia shares her clinical approach to helping women become better informed advocates for their own health.


    A warm, thought-provoking conversation about knowledge, self-advocacy and restoring balance to women's healthcare.

    48 min
  • Why Better Science Doesn't Always Win

    What if the biggest challenge in biotech isn't innovation, but adoption?

    I'm joined by Holley Miller, CEO of Grey Matter Marketing, to explore why better science doesn't automatically win.

    We talk about why people buy outcomes rather than products, why emotion can open the door before data earns belief, the importance of solving an urgent problem, and why being different can sometimes matter more than simply being better.

    Holley also shares her own entrepreneurial and leadership journey, the value of non-obvious thinking, taking career risks and giving yourself permission to fail.

    A thought-provoking conversation about innovation, human behaviour and what it really takes to turn a great idea into something people will actually adopt.

    40 min
  • From Scientist to CEO

    Amy Walker didn't set out to become a CEO.

    In this episode of She Leads Biotech, I’m joined by Amy, CEO of 4basebio, to explore how a career that began in science evolved into leading a growing biotech company.

    We talk about growing alongside a business, stepping beyond your original expertise, building the right leadership team and culture, and the technology changing the future of DNA manufacturing and advanced therapies.

    It’s a conversation about science, leadership, career progression and being willing to take opportunities you never originally planned for.

    #SheLeadsBiotech #Biotech #WomenInBiotech #BiotechLeadership #DNAManufacturing #AdvancedTherapies

    38 min
  • Better Science Starts with Better Questions

    What happens when you reach one of the most senior positions in global drug discovery — and decide the next step is to leave the security of Big Pharma behind?

    In this episode of She Leads Biotech, I’m joined by Karin Conde-Knape, PhD, Chief Science Officer at Valo Health, whose international career has taken her through leadership roles at Roche, Johnson & Johnson and Novo Nordisk.

    We talk about why Karin believes better drug discovery needs to start with human data, how asking the right questions earlier can prevent years of time and investment being committed to the wrong path, and where data, experience and intuition belong in scientific decision-making.

    We also explore Karin’s decision to move from Big Pharma to biotech — what she describes as an “easier choice, not a comfortable choice” — and why impact, people and purpose became increasingly important at this stage of her career.

    Our conversation moves beyond the science into leadership: creating psychological safety, challenging the thought process rather than the individual, developing resilient future leaders, embracing AI and new technologies, and building teams that genuinely want to follow you.

    A fascinating conversation about drug discovery, human data, innovation, career courage and the leadership required to turn better questions into better science.

    37 min

About She Leads Biotech

From the publisher's feed

This is She Leads Biotech, a podcast where we have real conversations with women leading the charge in innovation, research, and entrepreneurship in the bioscience space. Each episode offers a candid…